secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solana Co (HSDT)
CIK:        0001610853
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0001558370-24-004251
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Helius Medical Q4 revenue down 52% YoY; net loss per share $1.47 vs $8.66
-------------------------------------------------------------------------

- Q4 2023 revenue $134K, down from $282K in Q4 2022, due to US PTAP expiration and lower Canada sales.
- Net loss $1.0M in Q4 2023 vs $4.9M in Q4 2022; basic EPS loss $1.47 vs $8.66.
- FY2023 revenue $644K vs $787K; net loss $8.9M vs $14.1M; operating loss $12.4M vs $15.5M.
- Cash $5.2M at Dec 31, 2023; raised $1.3M in Q1 2024 ATM at avg $9.27/share, runway to Q3 2024.
- CMS assigned HCPCS codes for PoNS mouthpiece/controller effective Apr 1, 2024; targeting Medicare reimbursement by Oct 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/0001558370-24-004251-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610853/000155837024004251/hsdt-20240328x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-004251

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer